Skip to main content
Caplight Logo









MNDL Bio

MNDL Bio

Private
Tel AvivHealthcare & Life Scienceshttps://www.mndl.bio/

Last Round

Seed

Sep 8, 2024

Total Funding Raised

$2.1M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

MNDL Bio is a synthetic biology company that provides an AI-powered computational platform to optimize gene expression for recombinant protein production.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

synthetic biologygene expression optimizationprotein productionsynbioprecision fermentationDNA sequence designbiomanufacturingrecombinant proteincomputational biologyAI-driven R&Din silico designbiotech SaaShost optimizationfoodtechbio-design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MNDL Bio Comparables

Compare MNDL Bio with similar companies based on industry and business-model similarity.

MNDL Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Avenue Biosciences
82%
Scala Biodesign
82%
ExpressionEdits
81%

MNDL Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 8, 2024
GrantJul 1, 2023

Key People

Founding team and executive leadership

Steve Grün

Co-founder & CEO

Founding Team

MNDL Bio Investors

Notable investors and investment history

MNDL Bio investors
InvestorRounds
Israel Innovation AuthoritySeed
CPT CapitalSeed
Earth & Beyond VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2026

    Grew 40% QoQ, from 10 to 14 employees.

  • Jul 17, 2026

    Grew 50% QoQ, from 10 to 15 employees.

MNDL Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MNDL Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MNDL Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range8
Year Founded2023
Last FundingSep 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?